Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome

NCT01676597 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hepatopulmonary Syndrome

Interventions

DRUG: pentoxifylline and rifaximin
DRUG: Pentoxifylline and placebo

Sponsor

Institute of Liver and Biliary Sciences, India